Gregory M. Maggio

Psychiatry

3901 Rainbow Blvd
Kansas City, KS 66160

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration.

Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration.

Journal: Kansas journal of medicine

Published: April 21, 2022

Showing 1-1 of 1

Last Updated: 09/26/2026